• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传性神经退行性疾病的眼部表现。

Ophthalmic manifestations of inherited neurodegenerative disorders.

机构信息

Department of Ophthalmology, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand.

Centre for Brain Research, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand.

出版信息

Nat Rev Neurol. 2014 Jun;10(6):349-62. doi: 10.1038/nrneurol.2014.79. Epub 2014 May 20.

DOI:10.1038/nrneurol.2014.79
PMID:24840976
Abstract

Ophthalmic findings are common features of neurodegenerative disorders and, in addition to being clinically important, have emerged as potentially useful biomarkers of disease progression in several conditions. Clinically, these visual system abnormalities can be a clue to diagnosis, as well as being a prominent cause of disability in affected patients. In this Review, we describe the various afferent visual system and other ophthalmic features of inherited neurodegenerative disorders, including the muscular dystrophies, Friedreich ataxia, the spinocerebellar ataxias, hereditary spastic paraplegia, Charcot-Marie-Tooth disease, and other conditions. We focus on the expanding role of optical coherence tomography in diagnostic imaging of the retina and optic nerve head, and the possible use of ophthalmic findings as biomarkers of disease severity in hereditary neurodegenerative disorders. In addition, we discuss the ophthalmic manifestations and treatment implications of mitochondrial dysfunction, which is a feature of many inherited neurodegenerative diseases.

摘要

眼科发现是神经退行性疾病的常见特征,除了具有临床重要性外,在几种情况下已成为疾病进展的潜在有用生物标志物。临床上,这些视觉系统异常可能是诊断的线索,也是受影响患者残疾的主要原因。在这篇综述中,我们描述了遗传性神经退行性疾病的各种传入视觉系统和其他眼科特征,包括肌肉营养不良、弗里德里希共济失调、脊髓小脑共济失调、遗传性痉挛性截瘫、Charcot-Marie-Tooth 病和其他疾病。我们专注于光相干断层扫描在视网膜和视神经头诊断成像中的扩展作用,以及眼科发现作为遗传性神经退行性疾病疾病严重程度的生物标志物的可能性。此外,我们还讨论了线粒体功能障碍的眼科表现和治疗意义,线粒体功能障碍是许多遗传性神经退行性疾病的特征。

相似文献

1
Ophthalmic manifestations of inherited neurodegenerative disorders.遗传性神经退行性疾病的眼部表现。
Nat Rev Neurol. 2014 Jun;10(6):349-62. doi: 10.1038/nrneurol.2014.79. Epub 2014 May 20.
2
The optic nerve: a "mito-window" on mitochondrial neurodegeneration.视神经:线粒体神经退行性变的“线粒体窗”。
Mol Cell Neurosci. 2013 Jul;55(100):62-76. doi: 10.1016/j.mcn.2012.08.004. Epub 2012 Aug 15.
3
Optical coherence tomography in autosomal recessive spastic ataxia of Charlevoix-Saguenay.常染色体隐性痉挛性共济失调型 Charlevoix-Saguenay 的光学相干断层扫描。
Brain. 2018 Apr 1;141(4):989-999. doi: 10.1093/brain/awy028.
4
Classifications of neurogenetic diseases: An increasingly complex problem.神经遗传性疾病的分类:一个日益复杂的问题。
Rev Neurol (Paris). 2016 Jun-Jul;172(6-7):339-49. doi: 10.1016/j.neurol.2016.04.005. Epub 2016 May 27.
5
Neuro-Ophthalmic Manifestations of Pediatric Neurodegenerative Disease.小儿神经退行性疾病的神经眼科表现
J Neuroophthalmol. 2017 Sep;37 Suppl 1:S4-S13. doi: 10.1097/WNO.0000000000000549.
6
Hereditary optic neuropathies.遗传性视神经病变
Eye (Lond). 2004 Nov;18(11):1144-60. doi: 10.1038/sj.eye.6701591.
7
The role of mitochondria in inherited neurodegenerative diseases.线粒体在遗传性神经退行性疾病中的作用。
J Neurochem. 2006 Jun;97(6):1659-75. doi: 10.1111/j.1471-4159.2006.03990.x.
8
Optical Coherence Tomography in the Management of Skull Base Fibrous Dysplasia with Optic Nerve Involvement.光学相干断层扫描在伴有视神经受累的颅底骨纤维异常增殖症治疗中的应用
World Neurosurg. 2018 Jan;109:e546-e553. doi: 10.1016/j.wneu.2017.10.018. Epub 2017 Oct 13.
9
PNPLA6 mutations cause Boucher-Neuhauser and Gordon Holmes syndromes as part of a broad neurodegenerative spectrum.PNPLA6 突变导致布歇尔-努厄豪泽综合征和戈登-霍姆斯综合征,属于广泛的神经退行性疾病谱的一部分。
Brain. 2014 Jan;137(Pt 1):69-77. doi: 10.1093/brain/awt326. Epub 2013 Dec 19.
10
Charcot-Marie-Tooth disease and related disorders: an evolving landscape.遗传性运动感觉神经病和相关疾病:一个不断发展的领域。
Curr Opin Neurol. 2019 Oct;32(5):641-650. doi: 10.1097/WCO.0000000000000735.

引用本文的文献

1
The New Zealand Genetic Frontotemporal Dementia Study (FTDGeNZ): a longitudinal study of pre-symptomatic biomarkers.新西兰遗传性额颞叶痴呆研究(FTDGeNZ):一项针对症状前生物标志物的纵向研究。
J R Soc N Z. 2022 Jul 28;53(4):511-531. doi: 10.1080/03036758.2022.2101483. eCollection 2023.
2
Severe Dry Eye Disease in Charcot-Marie-Tooth Disease: A Comprehensive Case Report.Charcot-Marie-Tooth 病中的严重干燥性眼疾:全面病例报告。
Am J Case Rep. 2023 Nov 15;24:e941094. doi: 10.12659/AJCR.941094.
3
Genipin relieves diabetic retinopathy by down-regulation of advanced glycation end products via the mitochondrial metabolism related signaling pathway.

本文引用的文献

1
A small natural molecule promotes mitochondrial fusion through inhibition of the deubiquitinase USP30.一种小分子天然物质通过抑制去泛素化酶USP30来促进线粒体融合。
Cell Res. 2014 Apr;24(4):482-96. doi: 10.1038/cr.2014.20. Epub 2014 Feb 11.
2
Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial.脉络膜视网膜炎患者的视网膜基因治疗:1/2 期临床试验的初步结果。
Lancet. 2014 Mar 29;383(9923):1129-37. doi: 10.1016/S0140-6736(13)62117-0. Epub 2014 Jan 16.
3
C19orf12 mutation leads to a pallido-pyramidal syndrome.
京尼平通过线粒体代谢相关信号通路下调晚期糖基化终产物来缓解糖尿病视网膜病变。
World J Diabetes. 2023 Sep 15;14(9):1349-1368. doi: 10.4239/wjd.v14.i9.1349.
4
MFN1 augmentation prevents retinal degeneration in a Charcot-Marie-Tooth type 2A mouse model.MFN1增强可预防2A型夏科-马里-图斯病小鼠模型中的视网膜变性。
iScience. 2023 Feb 25;26(3):106270. doi: 10.1016/j.isci.2023.106270. eCollection 2023 Mar 17.
5
Retinal and Visual Pathways Involvement in Carriers of Friedreich's Ataxia.弗里德赖希共济失调携带者的视网膜和视觉通路受累情况。
Diagnostics (Basel). 2022 Dec 12;12(12):3135. doi: 10.3390/diagnostics12123135.
6
A novel homozygous variant in the gene presenting with childhood optic nerve atrophy.该基因中一个新的纯合变异体,表现为儿童视神经萎缩。
Am J Ophthalmol Case Rep. 2022 Feb 16;26:101400. doi: 10.1016/j.ajoc.2022.101400. eCollection 2022 Jun.
7
The Retina in Patients With Triple A Syndrome: A Window Into Neurodegeneration?三重 A 综合征患者的视网膜:神经退行性变的窗口?
Front Endocrinol (Lausanne). 2021 Nov 12;12:729056. doi: 10.3389/fendo.2021.729056. eCollection 2021.
8
Computer Vision for Brain Disorders Based Primarily on Ocular Responses.主要基于眼部反应的脑疾病计算机视觉技术
Front Neurol. 2021 Apr 21;12:584270. doi: 10.3389/fneur.2021.584270. eCollection 2021.
9
Clinical Characteristics, Differential Diagnosis and Genetic Analysis of Concentric Retinitis Pigmentosa.同心性视网膜色素变性的临床特征、鉴别诊断及基因分析
Life (Basel). 2021 Mar 22;11(3):260. doi: 10.3390/life11030260.
10
Ophthalmic Manifestations and Genetics of the Polyglutamine Autosomal Dominant Spinocerebellar Ataxias: A Review.多聚谷氨酰胺常染色体显性遗传性脊髓小脑共济失调的眼科表现与遗传学:综述
Front Neurosci. 2020 Aug 21;14:892. doi: 10.3389/fnins.2020.00892. eCollection 2020.
C19orf12 突变导致苍白球-锥体综合征。
Gene. 2014 Mar 10;537(2):352-6. doi: 10.1016/j.gene.2013.11.039. Epub 2013 Dec 17.
4
Mitochondrial fusion and fission proteins: novel therapeutic targets for combating cardiovascular disease.线粒体融合与裂变蛋白:对抗心血管疾病的新型治疗靶点。
Br J Pharmacol. 2014 Apr;171(8):1890-906. doi: 10.1111/bph.12516.
5
Disease progression in patients with single, large-scale mitochondrial DNA deletions.单一大规模线粒体 DNA 缺失患者的疾病进展。
Brain. 2014 Feb;137(Pt 2):323-34. doi: 10.1093/brain/awt321. Epub 2013 Nov 25.
6
Retinal thinning and correlation with functional disability in patients with Parkinson's disease.帕金森病患者的视网膜变薄与功能障碍的相关性。
Br J Ophthalmol. 2014 Mar;98(3):350-5. doi: 10.1136/bjophthalmol-2013-304152. Epub 2013 Nov 25.
7
Mitochondrial enhancement for neurodegenerative movement disorders: a systematic review of trials involving creatine, coenzyme Q10, idebenone and mitoquinone.线粒体增强治疗神经退行性运动障碍:涉及肌酸、辅酶 Q10、艾地苯醌和米托醌的临床试验的系统评价。
CNS Drugs. 2014 Jan;28(1):63-8. doi: 10.1007/s40263-013-0124-4.
8
Mitochondrial membrane protein-associated neurodegeneration (MPAN).线粒体膜蛋白相关神经退行性变(MPAN)。
Int Rev Neurobiol. 2013;110:73-84. doi: 10.1016/B978-0-12-410502-7.00004-1.
9
Epiretinal membrane: a treatable cause of visual disability in myotonic dystrophy type 1.视网膜前膜:1 型强直性肌营养不良致视力障碍的可治疗病因。
J Neurol. 2014 Jan;261(1):37-44. doi: 10.1007/s00415-013-7141-6. Epub 2013 Oct 17.
10
Retinal segmentation as noninvasive technique to demonstrate hyperplasia in ataxia of Charlevoix-Saguenay.利用视网膜分割技术无创性地显示小脑共济失调-萨格奈(Charlevoix-Saguenay)的增生。
Invest Ophthalmol Vis Sci. 2013 Oct 29;54(10):7137-42. doi: 10.1167/iovs.13-12726.